Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11300505rdf:typepubmed:Citationlld:pubmed
pubmed-article:11300505lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:11300505lifeskim:mentionsumls-concept:C0025664lld:lifeskim
pubmed-article:11300505lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:11300505lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:11300505lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:11300505lifeskim:mentionsumls-concept:C0005064lld:lifeskim
pubmed-article:11300505lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:11300505lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:11300505lifeskim:mentionsumls-concept:C0009830lld:lifeskim
pubmed-article:11300505lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:11300505pubmed:issue2lld:pubmed
pubmed-article:11300505pubmed:dateCreated2001-4-12lld:pubmed
pubmed-article:11300505pubmed:abstractTextBenzodiazepines are frequently abused by heroin users, but not all compounds have shown the same abuse liability. We developed an analytical method that was able to detect various benzodiazepine compounds in a single run. Enzymatically hydrolyzed urine underwent a liquid-liquid extraction procedure with chloroform/isopropanol (9:1) at pH 8-9 followed by a solid-liquid clean-up (Bond Elut TCA C18) to obtain appropriate extracts for HPLC analysis. Mobile phase composition was optimized by means of the linear solvation energy relationship methodology based on Reichardt's normalized solvatochromic parameter (E(T)N). The method was validated for the simultaneous detection and quantitation of alprazolam, alpha-hydroxyalprazolam, oxazepam, 7-aminoflunitrazepam, flunitrazepam, nordiazepam, lorazepam, and diazepam. The prevalence of benzodiazepine consumption in 229 opioid-dependent subjects on methadone-maintenance treatment was 48%. Oxazepam and nordiazepam were the benzodiazepines most frequently recoved in urine samples. The prevalence of alprazolam use (40%) was higher than that of flunitrazepam (10%).lld:pubmed
pubmed-article:11300505pubmed:languageenglld:pubmed
pubmed-article:11300505pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11300505pubmed:citationSubsetIMlld:pubmed
pubmed-article:11300505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11300505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11300505pubmed:statusMEDLINElld:pubmed
pubmed-article:11300505pubmed:monthMarlld:pubmed
pubmed-article:11300505pubmed:issn0146-4760lld:pubmed
pubmed-article:11300505pubmed:authorpubmed-author:SeguraJJlld:pubmed
pubmed-article:11300505pubmed:authorpubmed-author:BarbosaJJlld:pubmed
pubmed-article:11300505pubmed:authorpubmed-author:TorrentRRlld:pubmed
pubmed-article:11300505pubmed:authorpubmed-author:SeguraMMlld:pubmed
pubmed-article:11300505pubmed:authorpubmed-author:CastilloCClld:pubmed
pubmed-article:11300505pubmed:authorpubmed-author:FarréMMlld:pubmed
pubmed-article:11300505pubmed:authorpubmed-author:de la TorreRRlld:pubmed
pubmed-article:11300505pubmed:issnTypePrintlld:pubmed
pubmed-article:11300505pubmed:volume25lld:pubmed
pubmed-article:11300505pubmed:ownerNLMlld:pubmed
pubmed-article:11300505pubmed:authorsCompleteYlld:pubmed
pubmed-article:11300505pubmed:pagination130-6lld:pubmed
pubmed-article:11300505pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11300505pubmed:meshHeadingpubmed-meshheading:11300505...lld:pubmed
pubmed-article:11300505pubmed:meshHeadingpubmed-meshheading:11300505...lld:pubmed
pubmed-article:11300505pubmed:meshHeadingpubmed-meshheading:11300505...lld:pubmed
pubmed-article:11300505pubmed:meshHeadingpubmed-meshheading:11300505...lld:pubmed
pubmed-article:11300505pubmed:meshHeadingpubmed-meshheading:11300505...lld:pubmed
pubmed-article:11300505pubmed:meshHeadingpubmed-meshheading:11300505...lld:pubmed
pubmed-article:11300505pubmed:meshHeadingpubmed-meshheading:11300505...lld:pubmed
pubmed-article:11300505pubmed:meshHeadingpubmed-meshheading:11300505...lld:pubmed
pubmed-article:11300505pubmed:meshHeadingpubmed-meshheading:11300505...lld:pubmed
pubmed-article:11300505pubmed:meshHeadingpubmed-meshheading:11300505...lld:pubmed
pubmed-article:11300505pubmed:meshHeadingpubmed-meshheading:11300505...lld:pubmed
pubmed-article:11300505pubmed:year2001lld:pubmed
pubmed-article:11300505pubmed:articleTitleAnalytical methodology for the detection of benzodiazepine consumption in opioid-dependent subjects.lld:pubmed
pubmed-article:11300505pubmed:affiliationUnitat de Farmacologia, Institut Municipal d'Investigació Mèdica IMIM, Barcelona, Spain.lld:pubmed
pubmed-article:11300505pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11300505pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:11300505pubmed:publicationTypeValidation Studieslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11300505lld:pubmed